Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-003685
Filing Date
2013-01-17
Accepted
2013-01-17 17:25:48
Documents
1
Period of Report
2013-01-15

Document Format Files

Seq Description Document Type Size
1 SHARES SOLD UNDER 10B5-1 PLAN rrd367090.html 4  
1 SHARES SOLD UNDER 10B5-1 PLAN rrd367090.xml 4 3927
  Complete submission text file 0001181431-13-003685.txt   5446
Mailing Address NABI PHARMACEUTICALS 5800 PARK OF COMMERCE BLVD N.W. BOCA RATON FL 33487
Business Address
SMITH MARK L (Reporting) CIK: 0001206467 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35073 | Film No.: 13535657

Mailing Address 345 INVERNESS DRIVE SOUTH, BUILDING C Suite 310 ENGLEWOOD CO 80112
Business Address 345 INVERNESS DRIVE SOUTH, BUILDING C Suite 310 ENGLEWOOD CO 80112 303-858-8358
Gevo, Inc. (Issuer) CIK: 0001392380 (see all company filings)

EIN.: 870747704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2860 Industrial Organic Chemicals